Aligos Therapeutics Stock Performance

Aligos Therapeutics Relative Risk vs. Return Landscape

If you would invest  823.00  in Aligos Therapeutics on November 19, 2025 and sell it today you would lose (155.00) from holding Aligos Therapeutics or give up 18.83% of portfolio value over 90 days. Aligos Therapeutics is currently does not generate positive expected returns and assumes 5.6637% risk (volatility on return distribution) over the 90 days horizon. In different words, 50% of stocks are less volatile than Aligos, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Aligos Therapeutics is expected to under-perform the market. In addition to that, the company is 7.5 times more volatile than its market benchmark. It trades about -0.03 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.16 per unit of volatility.

Aligos Therapeutics Target Price Odds to finish over Current Price

Given the investment horizon of 90 days Aligos Therapeutics has a beta of 0.78. This suggests as returns on the market go up, Aligos Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Aligos Therapeutics will be expected to be much smaller as well. Additionally Aligos Therapeutics has an alpha of 0.1266, implying that it can generate a 0.13 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Aligos Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Aligos Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.86 6.52 12.18 Details

Intrinsic Valuation Low Real High 5.93 21.93 27.59 Details

3 Analysts Consensus Low Target High 62.06 68.20 75.70 Details

Earnings Estimates (0) Low Projected EPS High -2.38 -1.9 -0.61 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Aligos Therapeutics. Your research has to be compared to or analyzed against Aligos Therapeutics' peers to derive any actionable benefits. When done correctly, Aligos Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Aligos Therapeutics.

Aligos Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Aligos Therapeutics is not an exception. The market had few large corrections towards the Aligos Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Aligos Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Aligos Therapeutics within the framework of very fundamental risk indicators.

Aligos Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Aligos Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Aligos Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Aligos Therapeutics Price Density Drivers

Aligos Therapeutics Fundamentals Growth

When running Aligos Therapeutics' price analysis, check to measure Aligos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aligos Therapeutics is operating at the current time. Most of Aligos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aligos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aligos Therapeutics' price. Additionally, you may evaluate how the addition of Aligos Therapeutics to your portfolios can decrease your overall portfolio volatility.